Skip to main content
. 2021 Dec 20;20:478. doi: 10.1186/s12936-021-04009-1

Fig. 2.

Fig. 2

Scatter plot of max post-baseline ALT absolute value versus cipargamin AUC (area under the curve) by treatment group (Safety set)